CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Gabapentin

加巴喷丁 杂质对照品Gabapentin Impurities

EP34 个杂质条目34 impurity entries

本页汇总 加巴喷丁 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Gabapentin with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 加巴喷丁(Gabapentin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and Validation of 2-Azaspiro [4,5] Decan-3-One (Impurity A) in Gabapentin Determination Method Using qNMR Spectroscopy
    Molecules (Basel, Switzerland) · 2021 · Kuz'mina NE et al.  ·  PMID 33809747  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products
    Journal of pharmaceutical and biomedical analysis · 2007 · Ciavarella AB et al.  ·  PMID 17275240  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products
    Journal of pharmaceutical and biomedical analysis · 2016 · Ragham PK, Chandrasekhar KB  ·  PMID 27018505  ·  DOI
  4. 分析方法Analytical MethodsHPLC Analytical Method Development and Validation of Gabapentin through Chemical Derivatization with Catechol as a Chromophore
    International journal of analytical chemistry · 2022 · Abualhasan M et al.  ·  PMID 36225344  ·  DOI
  5. 分析方法Analytical MethodsQuantification of Gabapentin, Lacosamide, Perampanel, Pregabalin, Rufinamide, and Vigabatrin in Serum Using Liquid Chromatography-Tandem Mass Spectrometry
    Methods in molecular biology (Clifton, N.J.) · 2024 · Chong E et al.  ·  PMID 38036807  ·  DOI

加巴喷丁 —— 原料药与杂质对照品Gabapentin — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Gabapentin structure
EP原料药 APIAPI
加巴喷丁Gabapentin
Gabapentin
CAS No.60142-96-3
Chemical FormulaC9H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 1 (Gabapentin EP Impurity A) structure
EPA
加巴喷丁杂质1 (加巴喷丁EP杂质A)Gabapentin Impurity 1 (Gabapentin EP Impurity A)
Gabapentin Impurity 1 (Gabapentin EP Impurity A)
CAS No.64744-50-9
Chemical FormulaC9H15NO
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 2 (Gabapentin EP Impurity B) structure
EPB
加巴喷丁杂质2 (加巴喷丁EP杂质B)Gabapentin Impurity 2 (Gabapentin EP Impurity B)
Gabapentin Impurity 2 (Gabapentin EP Impurity B)
CAS No.133481-09-1
Chemical FormulaC9H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 4 (Gabapentin EP Impurity D) structure
EPD
加巴喷丁杂质4 (加巴喷丁EP杂质D)Gabapentin Impurity 4 (Gabapentin EP Impurity D)
Gabapentin Impurity 4 (Gabapentin EP Impurity D)
CAS No.1076198-17-8
Chemical FormulaC18H29NO3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 5 (Gabapentin EP Impurity E) structure
EPE
加巴喷丁杂质5 (加巴喷丁EP杂质E)Gabapentin Impurity 5 (Gabapentin EP Impurity E)
Gabapentin Impurity 5 (Gabapentin EP Impurity E)
CAS No.67950-95-2
Chemical FormulaC9H14O4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 6 (Gabapentin EP Impurity G) structure
EPG
加巴喷丁杂质6 (加巴喷丁EP杂质G)Gabapentin Impurity 6 (Gabapentin EP Impurity G)
Gabapentin Impurity 6 (Gabapentin EP Impurity G)
CAS No.1500558-49-5
Chemical FormulaC10H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 3 structure
3
加巴喷丁杂质3Gabapentin Impurity 3
Gabapentin Impurity 3
CAS No.4172-99-0
Chemical FormulaC9H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 7 structure
7
加巴喷丁杂质7Gabapentin Impurity 7
Gabapentin Impurity 7
CAS No.138799-98-1
Chemical FormulaC10H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 8 structure
8
加巴喷丁杂质8Gabapentin Impurity 8
Gabapentin Impurity 8
CAS No.1083246-63-2
Chemical FormulaC18H32N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 9 structure
9
加巴喷丁杂质9Gabapentin Impurity 9
Gabapentin Impurity 9
CAS No.1281568-83-9
Chemical FormulaC13H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 10 structure
10
加巴喷丁杂质10Gabapentin Impurity 10
Gabapentin Impurity 10
CAS No.478296-72-9
Chemical FormulaC16H27NO6
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 11 structure
11
加巴喷丁杂质11Gabapentin Impurity 11
Gabapentin Impurity 11
CAS No.4355-15-1
Chemical FormulaC12H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 12 structure
12
加巴喷丁杂质12Gabapentin Impurity 12
Gabapentin Impurity 12
CAS No.3913-98-2
Chemical FormulaC8H17N
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 14 structure
14
加巴喷丁杂质14Gabapentin Impurity 14
Gabapentin Impurity 14
CAS No.99189-60-3
Chemical FormulaC10H17NO3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 15 structure
15
加巴喷丁杂质15Gabapentin Impurity 15
Gabapentin Impurity 15
CAS No.460711-35-7
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 16 structure
16
加巴喷丁杂质16Gabapentin Impurity 16
Gabapentin Impurity 16
CAS No.374795-39-8
Chemical FormulaC16H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 18 structure
18
加巴喷丁杂质18Gabapentin Impurity 18
Gabapentin Impurity 18
CAS No.227626-55-3
Chemical FormulaC9H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 19 structure
19
加巴喷丁杂质19Gabapentin Impurity 19
Gabapentin Impurity 19
CAS No.277333-40-1
Chemical FormulaC9H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 21 structure
21
加巴喷丁杂质21Gabapentin Impurity 21
Gabapentin Impurity 21
CAS No.1082040-31-0
Chemical FormulaC7H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 25 structure
25
加巴喷丁杂质25Gabapentin Impurity 25
Gabapentin Impurity 25
CAS No.176445-80-0
Chemical FormulaC8H18N2O
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 26 structure
26
加巴喷丁杂质26Gabapentin Impurity 26
Gabapentin Impurity 26
CAS No.4355-11-7
Chemical FormulaC10H16O4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 27 structure
27
加巴喷丁杂质27Gabapentin Impurity 27
Gabapentin Impurity 27
CAS No.227626-60-0
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 28 structure
28
加巴喷丁杂质28Gabapentin Impurity 28
Gabapentin Impurity 28
CAS No.1130-32-1
Chemical FormulaC10H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 30 structure
30
加巴喷丁杂质30Gabapentin Impurity 30
Gabapentin Impurity 30
CAS No.882847-19-0
Chemical FormulaC24H27NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 31 structure
31
加巴喷丁杂质31Gabapentin Impurity 31
Gabapentin Impurity 31
CAS No.1990449-64-3
Chemical FormulaC21H35NO11
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 32 structure
32
加巴喷丁杂质32Gabapentin Impurity 32
Gabapentin Impurity 32
CAS No.4000-72-0
Chemical FormulaC7H15NO
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 33 structure
33
加巴喷丁杂质33Gabapentin Impurity 33
Gabapentin Impurity 33
CAS No.3164-73-6
Chemical FormulaC7H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 34 structure
34
加巴喷丁杂质34Gabapentin Impurity 34
Gabapentin Impurity 34
CAS No.54004-46-5
Chemical FormulaC8H16O2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 35 structure
35
加巴喷丁杂质35Gabapentin Impurity 35
Gabapentin Impurity 35
CAS No.1374635-87-6
Chemical FormulaC16H24BrClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 38 structure
38
加巴喷丁杂质38Gabapentin Impurity 38
Gabapentin Impurity 38
CAS No.3064817-66-6
Chemical FormulaC19H30N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 40 structure
40
加巴喷丁杂质40Gabapentin Impurity 40
Gabapentin Impurity 40
CAS No.1197-80-4
Chemical FormulaC9H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 41 structure
41
加巴喷丁杂质41Gabapentin Impurity 41
Gabapentin Impurity 41
CAS No.667465-00-1
Chemical FormulaC9H14O4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 42 structure
42
加巴喷丁杂质42Gabapentin Impurity 42
Gabapentin Impurity 42
CAS No.3049529-23-6
Chemical FormulaC18H29NO5
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 43 structure
43
加巴喷丁杂质43Gabapentin Impurity 43
Gabapentin Impurity 43
CAS No.1344032-05-8
Chemical FormulaC19H30N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Gabapentin Impurity 44 structure
44
加巴喷丁杂质44Gabapentin Impurity 44
Gabapentin Impurity 44
CAS No.3048030-55-0
Chemical FormulaC16H25NO5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

加巴喷丁 —— 研究文献与合成路线Gabapentin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 加巴喷丁 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Gabapentin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products
    Ragham PK, Chandrasekhar KB · Journal of pharmaceutical and biomedical analysis · 2016 · 被引 8cited 8
  2. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products
    Ciavarella AB, Gupta A, Sayeed VA, et al. · Journal of pharmaceutical and biomedical analysis · 2007 · 被引 19cited 19
  3. Material-sparing degradation-kinetics model for thermolabile drug stability assessment during twin-screw melt granulation - Insights with gabapentin
    Pradhan A, Yang F, Karan K, et al. · International journal of pharmaceutics · 2025 · 被引 1cited 1
  4. Effect of screw profile and processing conditions on physical transformation and chemical degradation of gabapentin during twin-screw melt granulation
    Kittikunakorn N, Sun CC, Zhang F · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2019 · 被引 20cited 20
  5. The stabilizing effect of moisture on the solid-state degradation of gabapentin
    Zong Z, Desai SD, Kaushal AM, et al. · AAPS PharmSciTech · 2011 · 被引 21cited 21
  6. Kinetic model for solid-state degradation of gabapentin
    Zong Z, Qiu J, Tinmanee R, et al. · Journal of pharmaceutical sciences · 2012 · 被引 19cited 19

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF GABAPENTIN
    GIOVANETTI ROBERTO, NICOLI ANDREA, VERZINI MASSIMO, SORIATO GIORGIO, et al. · 公开号 HR20110401THR20110401T · 2011
  2. PROCESS FOR THE PREPARATION OF GABAPENTIN
    DIVI MURALI KRISHNA PRASAD, PADAKANDLA GUNDU RAO, RAO MYSORE ASWATHA NARAYANA, NOWSHUDDIN SHAIK, et al. · 公开号 US2011306787US2011306787 · 2011
  3. Process for the preparation of Gabapentin
    DELOGU PIETRO, CORDERO LUCIA, DE ROSA SABRINA, PUNTIN GIULIO, et al. · 公开号 EP2368872EP2368872 · 2011
  4. PROCESS FOR THE PREPARATION OF GABAPENTIN
    ARRIGHI KATIUSCIA, CANNATA VINCENZO, CORCELLA FRANCESCO, MARCHIORO GAETANO, et al. · 公开号 US2009326266US2009326266 · 2009
  5. PROCESSES FOR THE PREPARATION AND PURIFICATION OF GABAPENTIN ENACARBIL
    BEN-MOHA-LERMAN ELENA, NIDAM TAMAR, COHEN MEITAL, AVHAR-MAYDAN SHARON, et al. · 公开号 WO2010063002WO2010063002 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

加巴喷丁 杂质谱研究要点Gabapentin — impurity profiling notes

下面这些是拿到 加巴喷丁 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Gabapentin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances